Developing a case study model for successful translation of stem cell therapies.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 20569687.
- Also identified by DOI 10.1016/j.stem.2010.05.008.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Cell therapies derived from pluripotent stem cells are entering the preclinical and early clinical development phase, but eventual translation faces many challenges. We describe a new approach by California to form global public-private "disease team" partnerships to enable new clinical opportunities to be evaluated in the complex regulatory environment.
Medical subject headings
- Cell- and Tissue-Based Therapy
- Clinical Trials as Topic
- Models, Econometric
- Pluripotent Stem Cells
- Research Support as Topic